SYNNEX Corp. (SNX) Tops Q2 EPS by 5c, Sales Miss; Guides Q3
Tweet
Share
E-mailGet Alerts SNX Hot Sheet
Price: $254.58 -0.25%
Revenue Growth %: +18.4%
Financial Fact:
Net income per common share - diluted: 1.47
Today's EPS Names:
OFLX, VAXX, NMRD, More
Revenue Growth %: +18.4%
Financial Fact:
Net income per common share - diluted: 1.47
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
SYNNEX Corp. (NYSE: SNX) reported Q2 EPS of $0.85, $0.05 better than the analyst estimate of $0.80. Revenue for the quarter came in at $2.5 billion versus the consensus estimate of $2.51 billion.
Sees Q3 2011 EPS of $0.88-$0.92, versus the consensus of $0.94. Sees Q3 2011 revenue of $2.54-$2.64 billion, versus the consensus of $2.65 billion.
Sees Q3 2011 EPS of $0.88-$0.92, versus the consensus of $0.94. Sees Q3 2011 revenue of $2.54-$2.64 billion, versus the consensus of $2.65 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
